Ideas For Profit | Will Sun Pharma's steady India business, US speciality portfolio help it do well in FY21?
In this edition of Ideas For Profit, Moneycontrol's Sakshi Batra decodes Sun Pharma Q1 results and suggests what strategy investors could adopt now.03-08-2020